MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy.
Revenue (Most Recent Fiscal Year) | $219.08M |
Net Income (Most Recent Fiscal Year) | $0.93M |
PE Ratio (Current Year Earnings Estimate) | 14.07 |
PE Ratio (Trailing 12 Months) | 18.52 |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 2.56 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.35 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 8.51 |
Pre-Tax Margin (Trailing 12 Months) | -0.28% |
Net Margin (Trailing 12 Months) | 0.45% |
Return on Equity (Trailing 12 Months) | 7.41% |
Return on Assets (Trailing 12 Months) | 4.34% |
Current Ratio (Most Recent Fiscal Quarter) | 2.68 |
Quick Ratio (Most Recent Fiscal Quarter) | 1.86 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.58 |
Inventory Turnover (Trailing 12 Months) | 2.39 |
Book Value per Share (Most Recent Fiscal Quarter) | $73.60 |
Earnings per Share (Most Recent Fiscal Quarter) | $1.46 |
Earnings per Share (Most Recent Fiscal Year) | $5.55 |
Diluted Earnings per Share (Trailing 12 Months) | $0.17 |
Exchange | NASDAQ |
Sector | Technology |
Industry | Scientific & Technical Instruments |
Common Shares Outstanding | 5.39M |
Free Float | 5.11M |
Market Capitalization | $545.55M |
Average Volume (Last 20 Days) | 0.04M |
Beta (Past 60 Months) | 0.83 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 5.20% |
Percentage Held By Institutions (Latest 13F Reports) | 90.60% |
Annual Dividend (Based on Last Quarter) | $0.64 |
Dividend Yield (Based on Last Quarter) | 0.63% |